{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:31:36Z","timestamp":1795120296658,"version":"4.10.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Atomic Energy Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sulfonamide derivatives are a significant class of medicinal compounds. Gold nanoparticles (AuNPs) offer precise cancer treatment through targeted delivery, boasting high drug-loading capacity and low toxicity. This study aimed to develop and evaluate 99mTc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as a tumor-targeting agent. A novel benzenesulfonamide derivative bearing a pyridine moiety was synthesized. Compound 3 (4-((3-cyano-4-(2,4-dichlorophenyl)-6-phenylpyridin-2-yl)amino)-N-(diaminomethylene)benzenesulfonamide) exhibited remarkable anti-cancer activity against MCF-7 cells. The chemical reduction method was employed to create compound 3-citrate-AuNPs. A comprehensive examination of the synthesized nano-platform was conducted, including zeta potential, size analysis, radiochemical yield, and in-vivo biodistribution in tumor-bearing mice. The nano-platform was successfully produced with good stability, optimal particle size (9\u00a0nm diameter for AuNPs), and high radiochemical purity for [<jats:sup>99m<\/jats:sup>Tc]Tc-compound 3 (88.31\u2009\u00b1\u20092.14%). In-vivo investigations revealed that intravenously administered [99mTc]Tc-compound 3-citrate-AuNPs accumulated in tumors with a high target-to-non-target ratio. The findings validate the efficacy of the novel [<jats:sup>99m<\/jats:sup>Tc]Tc-compound 3-citrate-AuNPs platform as a tumor-targeting agent.<\/jats:p>","DOI":"10.1038\/s41598-025-88862-z","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:17:23Z","timestamp":1738984643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["99mTc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as an auspicious tumour targeting"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7095-5978","authenticated-orcid":false,"given":"Adli A.","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma M.","family":"Essa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galal H.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurls E.","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"88862_CR1","unstructured":"Gelband, H. & Sloan, F. A. Cancer Control Opportunities in Low-and Middle-Income Countries (2007)."},{"key":"88862_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.ijbiomac.2022.11.214","volume":"225","author":"MA Ali","year":"2023","unstructured":"Ali, M. A., Aswathy, K., Munuswamy-Ramanujam, G. & Jaisankar, V. Pyridine and isoxazole substituted 3-formylindole-based chitosan Schiff base polymer: Antimicrobial, antioxidant and in vitro cytotoxicity studies on THP-1 cells. Int. J. Biol. Macromol. 225, 1575\u20131587 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"88862_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2023.101001","volume":"44","author":"PK Jami","year":"2023","unstructured":"Jami, P. K., Battula, S. R., Sandhya, J. & Parimi, U. D. Design, synthesis and biological evaluation of amide derivatives of isoxazole-imidazo [1,2-a] pyridine as anticancer agents. Chem. Data Collect. 44, 101001 (2023).","journal-title":"Chem. Data Collect."},{"key":"88862_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ejmech.2005.06.005","volume":"40","author":"AA Bekhit","year":"2005","unstructured":"Bekhit, A. A. & Baraka, A. M. Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents. Eur. J. Med. Chem. 40, 1405\u20131413 (2005).","journal-title":"Eur. J. Med. Chem."},{"key":"88862_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106402","volume":"133","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. A novel CDK8 inhibitor with poly-substituted pyridine core: Discovery and anti-inflammatory activity evaluation in vivo. Bioorg. Chem. 133, 106402 (2023).","journal-title":"Bioorg. Chem."},{"key":"88862_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ardp.201000088","volume":"343","author":"MA Al-Omar","year":"2010","unstructured":"Al-Omar, M. A., Amr, A. E. G. E. & Al-Salahi, R. A. Anti-inflammatory, analgesic, anticonvulsant and antiparkinsonian activities of some pyridine derivatives using 2,6-disubstituted isonicotinic acid hydrazides. Arch. Pharm. 343, 648\u2013656 (2010).","journal-title":"Arch. Pharm."},{"key":"88862_CR7","first-page":"707","volume":"62","author":"K Anwer","year":"2019","unstructured":"Anwer, K., Sayed, G., Hassanan, H. & Azab, M. Conventional and microwave synthesis of some new pyridine derivatives and evaluation their antimicrobial and cytotoxic activities. Egypt. J. Chem. 62, 707\u2013726 (2019).","journal-title":"Egypt. J. Chem."},{"key":"88862_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.134238","volume":"1273","author":"P Padmaja","year":"2023","unstructured":"Padmaja, P. et al. Design, synthesis, in vitro \u03b1-glucosidase inhibitory, antioxidant activity and molecular docking studies of novel pyridine linked imidazo [1,2-a] pyridine derivatives. J. Mol. Struct. 1273, 134238 (2023).","journal-title":"J. Mol. Struct."},{"key":"88862_CR9","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/acs.jmedchem.2c02135","volume":"66","author":"J Xia","year":"2023","unstructured":"Xia, J. et al. Discovery of quaternized pyridine-thiazole-pleuromutilin derivatives with broad-spectrum antibacterial and potent anti-MRSA activity. J. Med. Chem. 66, 5061\u20135078 (2023).","journal-title":"J. Med. Chem."},{"key":"88862_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/molecules27031103","volume":"27","author":"B Jin","year":"2022","unstructured":"Jin, B., Chen, J.-Y., Sheng, Z.-L., Sun, M.-Q. & Yang, H.-L. Synthesis, antibacterial and anthelmintic activity of novel 3-(3-pyridyl)-oxazolidinone-5-methyl ester derivatives. Molecules 27, 1103 (2022).","journal-title":"Molecules"},{"key":"88862_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100707","volume":"17","author":"J Husz\u00e1r","year":"2022","unstructured":"Husz\u00e1r, J. et al. hERG optimization of benzofuro\u2212pyridine and pyrazino\u2212indole derivatives as MCHR1 antagonists. ChemMedChem 17, e202100707 (2022).","journal-title":"ChemMedChem"},{"key":"88862_CR12","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.1038\/s41598-017-12795-5","volume":"7","author":"T-Y Wu","year":"2017","unstructured":"Wu, T.-Y., Cho, T.-Y., Lu, C.-K., Liou, J.-P. & Chen, M.-C. Identification of 7-(4\u2032-Cyanophenyl) indoline-1-benzenesulfonamide as a mitotic inhibitor to induce apoptotic cell death and inhibit autophagy in human colorectal cancer cells. Sci. Rep. 7, 12406 (2017).","journal-title":"Sci. Rep."},{"key":"88862_CR13","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/14756366.2017.1334650","volume":"32","author":"MM Ghorab","year":"2017","unstructured":"Ghorab, M. M., Alsaid, M. S., Soliman, A. M. & Ragab, F. A. VEGFR-2 inhibitors and apoptosis inducers: Synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety. J. Enzyme Inhib. Med. Chem. 32, 893\u2013907 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"88862_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.bmcl.2018.03.089","volume":"28","author":"MM Ghorab","year":"2018","unstructured":"Ghorab, M. M., Ragab, F. A., Heiba, H. I., El-Gazzar, M. G. & El-Gazzar, M. G. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors. Bioorg. Med. Chem. Lett. 28, 1464\u20131470 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"88862_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejmech.2017.04.077","volume":"136","author":"H-Z Zhang","year":"2017","unstructured":"Zhang, H.-Z. et al. Design, synthesis and antimicrobial evaluation of novel benzimidazole-incorporated sulfonamide analogues. Eur. J. Med. Chem. 136, 165\u2013183 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"88862_CR16","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.3390\/ijms25063348","volume":"25","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Novel anthraquinone-based benzenesulfonamide derivatives and their analogues as potent human carbonic anhydrase inhibitors with antitumor activity: Synthesis, biological evaluation, and in silico analysis. Int. J. Mol. Sci. 25, 3348 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"88862_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra, J. K. et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 16, 1\u201333 (2018).","journal-title":"J. Nanobiotechnol."},{"key":"88862_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12033-012-9623-7","volume":"55","author":"T Khushnud","year":"2013","unstructured":"Khushnud, T. & Mousa, S. A. Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer. Mol. Biotechnol. 55, 78\u201386 (2013).","journal-title":"Mol. Biotechnol."},{"key":"88862_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"88862_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ph17010126","volume":"17","author":"M Ali","year":"2024","unstructured":"Ali, M. et al. Recent developments in nanoparticle formulations for resveratrol encapsulation as an anticancer agent. Pharmaceuticals 17, 126 (2024).","journal-title":"Pharmaceuticals"},{"key":"88862_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/smll.200400093","volume":"1","author":"EE Connor","year":"2005","unstructured":"Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J. & Wyatt, M. D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1, 325\u2013327 (2005).","journal-title":"Small"},{"key":"88862_CR22","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/ar800035u","volume":"41","author":"CJ Murphy","year":"2008","unstructured":"Murphy, C. J. et al. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721\u20131730 (2008).","journal-title":"Acc. Chem. Res."},{"key":"88862_CR23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","volume":"60","author":"P Ghosh","year":"2008","unstructured":"Ghosh, P., Han, G., De, M., Kim, C. K. & Rotello, V. M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307\u20131315 (2008).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"88862_CR24","doi-asserted-by":"crossref","unstructured":"Giljohann, D. A. et al. Gold nanoparticles for biology and medicine. In: Spherical Nucleic Acids, 55\u201390 (2020).","DOI":"10.1201\/9781003056676-4"},{"key":"88862_CR25","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1021\/jp057170o","volume":"110","author":"PK Jain","year":"2006","unstructured":"Jain, P. K., Lee, K. S., El-Sayed, I. H. & El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J. Phys. Chem. B 110, 7238\u20137248 (2006).","journal-title":"J. Phys. Chem. B"},{"key":"88862_CR26","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1039\/b712170a","volume":"37","author":"RA Sperling","year":"2008","unstructured":"Sperling, R. A., Gil, P. R., Zhang, F., Zanella, M. & Parak, W. J. Biological applications of gold nanoparticles. Chem. Soc. Rev. 37, 1896\u20131908 (2008).","journal-title":"Chem. Soc. Rev."},{"key":"88862_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2217\/17435889.2.5.681","volume":"2","author":"X Huang","year":"2007","unstructured":"Huang, X., Jain, P. K., El-Sayed, I. H. & El-Sayed, M. A. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2, 681\u2013693 (2007).","journal-title":"Nanomedicine"},{"key":"88862_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1021\/nl052396o","volume":"6","author":"BD Chithrani","year":"2006","unstructured":"Chithrani, B. D., Ghazani, A. A. & Chan, W. C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662\u2013668 (2006).","journal-title":"Nano Lett."},{"key":"88862_CR29","doi-asserted-by":"publisher","first-page":"13549","DOI":"10.1073\/pnas.2232479100","volume":"100","author":"LR Hirsch","year":"2003","unstructured":"Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. 100, 13549\u201313554 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"88862_CR30","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1002\/anie.200602471","volume":"45","author":"J Kim","year":"2006","unstructured":"Kim, J. et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew. Chem. (Int. ed. Engl.) 45, 7754\u20137758 (2006).","journal-title":"Angew. Chem. (Int. ed. Engl.)"},{"key":"88862_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.msec.2014.09.019","volume":"45","author":"Y Fazaeli","year":"2014","unstructured":"Fazaeli, Y. et al. In vivo SPECT imaging of tumors by 198,199 Au-labeled graphene oxide nanostructures. Mater. Sci. Eng. C 45, 196\u2013204 (2014).","journal-title":"Mater. Sci. Eng. C"},{"key":"88862_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1039\/D3TB01976D","volume":"12","author":"MA Malik","year":"2024","unstructured":"Malik, M. A., Hashmi, A. A., Al-Bogami, A. S. & Wani, M. Y. Harnessing the power of gold: Advancements in anticancer gold complexes and functionalized nanoparticles. J. Mater. Chem. B 12, 552\u2013576 (2024).","journal-title":"J. Mater. Chem. B"},{"key":"88862_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jlcr.3380","volume":"59","author":"M Motaleb","year":"2016","unstructured":"Motaleb, M., Ibrahem, I., Ayoub, V. & Geneidi, A. Preparation and biological evaluation of 99mTc\u2013ropinirole as a novel radiopharmaceutical for brain imaging. J. Label. Compd. Radiopharm. 59, 147\u2013152 (2016).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"88862_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s10967-017-5310-2","volume":"314","author":"M Motaleb","year":"2017","unstructured":"Motaleb, M., Selim, A. A., El-Tawoosy, M., Sanad, M. & El-Hashash, M. Synthesis, radiolabeling and biological distribution of a new dioxime derivative as a potential tumor imaging agent. J. Radioanal. Nucl. Chem. 314, 1517\u20131522 (2017).","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"88862_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1515\/ract-2019-3208","volume":"108","author":"BM Essa","year":"2020","unstructured":"Essa, B. M., El-Mohty, A. A., El-Hashash, M. A. & Sakr, T. M. 99mTc-citrate-gold nanoparticles as a tumor tracer: Synthesis, characterization, radiolabeling and in-vivo studies. Radiochim. Acta 108, 809\u2013819 (2020).","journal-title":"Radiochim. Acta"},{"key":"88862_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119514","volume":"586","author":"WI El-Ghareb","year":"2020","unstructured":"El-Ghareb, W. I. et al. 99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent. Int. J. Pharm. 586, 119514 (2020).","journal-title":"Int. J. Pharm."},{"key":"88862_CR37","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.bjc.6601629","volume":"90","author":"C Osborne","year":"2004","unstructured":"Osborne, C., Wakeling, A. & Nicholson, R. Fulvestrant: An oestrogen receptor antagonist with a novel mechanism of action. Br. J. Cancer 90, S2\u2013S6 (2004).","journal-title":"Br. J. Cancer"},{"key":"88862_CR38","first-page":"6075","volume":"50","author":"HD Soule","year":"1990","unstructured":"Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075\u20136086 (1990).","journal-title":"Cancer Res."},{"key":"88862_CR39","doi-asserted-by":"crossref","unstructured":"Editors\u2010In\u2010Chief. Vol. 8, 265\u2013265 (Taylor & Francis, 1986).","DOI":"10.1080\/01652176.1986.9694054"},{"key":"88862_CR40","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath, J. C., Drummond, G., McLachlan, E., Kilkenny, C. & Wainwright, C. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br. J. Pharm. 160, 1573\u20131576 (2010).","journal-title":"Br. J. Pharm."},{"key":"88862_CR41","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ddr.20280","volume":"69","author":"WX Wan","year":"2008","unstructured":"Wan, W. X., Yang, M., Pan, S. R., Yu, C. J. & Wu, N. J. [99mTc] polyamine analogs as potential tumor imaging agent. Drug Dev. Res. 69, 520\u2013525 (2008).","journal-title":"Drug Dev. Res."},{"key":"88862_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejps.2015.05.002","volume":"76","author":"B Essa","year":"2015","unstructured":"Essa, B., Sakr, T., Khedr, M. A., El-Essawy, F. & El-Mohty, A. 99mTc-amitrole as a novel selective imaging probe for solid tumor: In silico and preclinical pharmacological study. Eur. J. Pharm. Sci. 76, 102\u2013109 (2015).","journal-title":"Eur. J. Pharm. Sci."},{"key":"88862_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/00397910701749682","volume":"38","author":"L Rong","year":"2008","unstructured":"Rong, L., Han, H., Jiang, H., Shi, D. & Tu, S. One-pot synthesis of 4,6-diaryl-2-oxo-1,2-dihydropyridine-3-carbonitriles via three-component cyclocondensation under solvent-free conditions. Synth. Commun. 38, 217\u2013224 (2008).","journal-title":"Synth. Commun."},{"key":"88862_CR44","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1246\/cl.2006.1314","volume":"35","author":"L Rong","year":"2006","unstructured":"Rong, L., Li, X., Wang, H., Shi, D. & Tu, S. An efficient and facile synthesis of 2-amino-4,6-diarylbenzene-1,3-dicarbonitrile and 1,2-dihydro-2-oxo-4,6-diarylpyridine-3-carbonitrile under solvent-free conditions. Chem. Lett. 35, 1314\u20131315 (2006).","journal-title":"Chem. Lett."},{"key":"88862_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/jhet.5570440641","volume":"44","author":"L Rong","year":"2007","unstructured":"Rong, L. et al. An efficient and facile procedure for the synthesis of 4,6-diaryl-2 (1H)-pyridones under solvent-free conditions. J. Heterocycl. Chem. 44, 1505\u20131508 (2007).","journal-title":"J. Heterocycl. Chem."},{"key":"88862_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12645-022-00123-0","volume":"13","author":"EM Ebrahem","year":"2022","unstructured":"Ebrahem, E. M., Sayed, G. H., Gad, G. N., Anwer, K. E. & Selim, A. A. Histopathology, pharmacokinetics and estimation of interleukin-6 levels of Moringa oleifera leaves extract-functionalized selenium nanoparticles against rats induced hepatocellular carcinoma. Cancer Nanotechnol. 13, 14 (2022).","journal-title":"Cancer Nanotechnol."},{"key":"88862_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/jlcr.3384","volume":"59","author":"M Motaleb","year":"2016","unstructured":"Motaleb, M., Adli, A., El-Tawoosy, M., Sanad, M. & AbdAllah, M. An easy and effective method for synthesis and radiolabelling of risedronate as a model for bone imaging. J. Label. Compd. Radiopharm. 59, 157\u2013163 (2016).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"88862_CR48","volume-title":"Zeta Potential in Colloid Science: Principles and Applications","author":"RJ Hunter","year":"2013","unstructured":"Hunter, R. J. Zeta Potential in Colloid Science: Principles and Applications Vol. 2 (Academic Press, 2013)."},{"key":"88862_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cocis.2019.11.006","volume":"44","author":"L Desch\u00eanes","year":"2019","unstructured":"Desch\u00eanes, L. & Lyklema, J. Entropy studies in interface science: An ageless tool. Curr. Opin. Colloid Interface Sci. 44, 220\u2013224 (2019).","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"88862_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcis.2006.12.075","volume":"309","author":"\u00c1V Delgado","year":"2007","unstructured":"Delgado, \u00c1. V., Gonz\u00e1lez-Caballero, F., Hunter, R., Koopal, L. & Lyklema, J. Measurement and interpretation of electrokinetic phenomena. J. Colloid Interface Sci. 309, 194\u2013224 (2007).","journal-title":"J. Colloid Interface Sci."},{"key":"88862_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41181-019-0086-z","volume":"5","author":"N Gillings","year":"2020","unstructured":"Gillings, N. et al. EANM guideline on the validation of analytical methods for radiopharmaceuticals. EJNMMI Radiopharm. Chem. 5, 1\u201329 (2020).","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"88862_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese, A., Tang, P. S. & Chan, W. C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1\u201316 (2012).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"88862_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.carbpol.2018.12.063","volume":"208","author":"X Cheng","year":"2019","unstructured":"Cheng, X., Zeng, X., Zheng, Y., Wang, X. & Tang, R. Surface-fluorinated and pH-sensitive carboxymethyl chitosan nanoparticles to overcome biological barriers for improved drug delivery in vivo. Carbohydr. Polym. 208, 59\u201369 (2019).","journal-title":"Carbohydr. Polym."},{"key":"88862_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"JV Jokerst","year":"2011","unstructured":"Jokerst, J. V., Lobovkina, T., Zare, R. N. & Gambhir, S. S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6, 715\u2013728 (2011).","journal-title":"Nanomedicine"},{"key":"88862_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505\u2013515 (2008).","journal-title":"Mol. Pharm."},{"key":"88862_CR56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","volume":"141","author":"P Decuzzi","year":"2010","unstructured":"Decuzzi, P. et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Controll. Release 141, 320\u2013327 (2010).","journal-title":"J. Controll. Release"},{"key":"88862_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","volume":"8","author":"AE Nel","year":"2009","unstructured":"Nel, A. E. et al. Understanding biophysicochemical interactions at the nano\u2013bio interface. Nat. Mater. 8, 543\u2013557 (2009).","journal-title":"Nat. Mater."},{"key":"88862_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00044-011-9558-8","volume":"21","author":"R Ding","year":"2012","unstructured":"Ding, R. et al. Preparation and bioevaluation of 99mTc nitrido radiopharmaceuticals with pyrazolo [1, 5-a] pyrimidine as tumor imaging agents. Med. Chem. Res. 21, 523\u2013530 (2012).","journal-title":"Med. Chem. Res."},{"key":"88862_CR59","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/jlcr.3060","volume":"56","author":"T Sakr","year":"2013","unstructured":"Sakr, T., El-Safoury, D., Awad, G. A. & Motaleb, M. Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging. J. Label. Compd. Radiopharm. 56, 392\u2013395 (2013).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"88862_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105846","volume":"125","author":"BM Essa","year":"2022","unstructured":"Essa, B. M., Selim, A. A., Sayed, G. H. & Anwer, K. E. Conventional and microwave-assisted synthesis, anticancer evaluation, 99mTc-coupling and In-vivo study of some novel pyrazolone derivatives. Bioorg. Chem. 125, 105846 (2022).","journal-title":"Bioorg. Chem."},{"key":"88862_CR61","first-page":"3251","volume":"6","author":"Y Fazaeli","year":"2011","unstructured":"Fazaeli, Y. et al. Grafting of a novel gold (III) complex on nanoporous MCM-41 and evaluation of its toxicity in Saccharomyces cerevisiae. Int. J. Nanomed. 6, 3251\u20133257 (2011).","journal-title":"Int. J. Nanomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88862-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88862-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88862-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:08:43Z","timestamp":1738987723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88862-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88862"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88862-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures and experimental protocols were performed following the International Guiding Principles for Biomedical Research Involving Animals and were approved by the research ethics committee, Ain Sams University, Egypt (code: ASU-SCI\/CHEM\/2024\/8\/1). The current study adheres to the ARRIVE guidelines for reporting in-vivo experiments ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"4687"}}